pubmed-article:17936625 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17936625 | lifeskim:mentions | umls-concept:C2717970 | lld:lifeskim |
pubmed-article:17936625 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:17936625 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:17936625 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:17936625 | lifeskim:mentions | umls-concept:C0000901 | lld:lifeskim |
pubmed-article:17936625 | pubmed:issue | 23 | lld:pubmed |
pubmed-article:17936625 | pubmed:dateCreated | 2007-11-6 | lld:pubmed |
pubmed-article:17936625 | pubmed:abstractText | The synthesis of novel dipeptidyl alpha-fluorovinyl sulfones using a Horner-Wadsworth-Emmons approach on N-Boc-l-phenylalaninal is described. Inhibitory assays against a Leishmania mexicana cysteine protease (CPB2.8DeltaCTE) revealed low biological activity. Relative rates of Michael additions of 2'-(phenethyl)thiol with vinyl sulfone and alpha-fluorovinyl sulfone were determined, and ab initio calculations on several Michael acceptor model structures were performed; both were in agreement with the biological testing results. | lld:pubmed |
pubmed-article:17936625 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936625 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936625 | pubmed:language | eng | lld:pubmed |
pubmed-article:17936625 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936625 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17936625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936625 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17936625 | pubmed:month | Dec | lld:pubmed |
pubmed-article:17936625 | pubmed:issn | 1464-3405 | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:CoombsGraham... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:MottramJeremy... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:El-SayedIbrah... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:AugustynsKoen... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:HaemersAchiel... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:Van der... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:WestropGareth... | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:SteertKoenK | lld:pubmed |
pubmed-article:17936625 | pubmed:author | pubmed-author:KrishtalAlisa... | lld:pubmed |
pubmed-article:17936625 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17936625 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17936625 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:17936625 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17936625 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17936625 | pubmed:pagination | 6563-6 | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:meshHeading | pubmed-meshheading:17936625... | lld:pubmed |
pubmed-article:17936625 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17936625 | pubmed:articleTitle | Dipeptidyl alpha-fluorovinyl Michael acceptors: synthesis and activity against cysteine proteases. | lld:pubmed |
pubmed-article:17936625 | pubmed:affiliation | Laboratory of Medicinal Chemistry, University of Antwerp, Universiteitsplein 1, BE-2610 Antwerp, Belgium. | lld:pubmed |
pubmed-article:17936625 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17936625 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:17936625 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17936625 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17936625 | lld:pubmed |